期刊
ELIFE
卷 5, 期 -, 页码 -出版社
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.20391
关键词
-
类别
资金
- American Heart Association [PRE22110004]
- National Institute of General Medical Sciences [T32-GM007067]
- National Heart, Lung, and Blood Institute [K08-HL121168, R01-HL120153, R01-HL121791, R01-HL119813]
- Burroughs Wellcome Fund
- National Institute on Aging [K01-AG046374, R01-AG044546, R01-AG051485, P50-AG005681-30.1]
- Knight Alzheimer's Disease Research Center [P50-AG005681-30.1]
- Alzheimer's Association [AARG-16-441560]
Genetic variations in the myeloid immune receptor TREM2 are linked to several neurodegenerative diseases. To determine how TREM2 variants contribute to these diseases, we performed structural and functional studies of wild-type and variant proteins. Our 3.1 angstrom TREM2 crystal structure revealed that mutations found in Nasu-Hakola disease are buried whereas Alzheimers disease risk variants are found on the surface, suggesting that these mutations have distinct effects on TREM2 function. Biophysical and cellular methods indicate that Nasu-Hakola mutations impact protein stability and decrease folded TREM2 surface expression, whereas Alzheimers risk variants impact binding to a TREM2 ligand. Additionally, the Alzheimers risk variants appear to epitope map a functional surface on TREM2 that is unique within the larger TREM family. These findings provide a guide to structural and functional differences among genetic variants of TREM2, indicating that therapies targeting the TREM2 pathway should be tailored to these genetic and functional differences with patient-specific medicine approaches for neurodegenerative disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据